Cite
MLA Citation
Anthony B El-Khoueiry et al.. “Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.” Lancet, vol. 389, no. 10088, 2017, pp. 2492–2502. http://access.bl.uk/ark:/81055/vdc_100046950464.0x000057